Get a Glimpse of Amgen's Future
564679
Documents released ahead of an FDA meeting foretell a tougher future for Amgen's top drugs.
238390
The company may be hinting at going public.
459925
A stock for dividend investors' watch list.
12117
AMD provides a sneak peek at how its pending quad-core chip will improve performance and save energy.
347902
Investors might be willing to forgive Tellabs (Nasdaq: TLAB) for missing expectations on its latest Q3 earnings. These things happen, especially when there are extenuating circumstances.
656775
Go behind the scenes of the 2007 Amgen Tour of California pro cycling race as it kicks off in San Francisco sporting the latest in bike tech. A photo journal by Michael Calore.
659281
The Amgen Tour of California, one of the premier events on the 2008 pro-cycling calendar, is making its way down the coast of the Golden State this week. Follow the race's every move in your browser, using a specialized Flash-based player.
438501
Here's what a newly approved drug looks like.
366464
Uncovering tomorrow's industry leaders today.
667689
The biotech firm advances to next stage of clinical studies in stem cell research.
639
Look at the big picture to find great companies.
665690
The developing biopharmaceutical company announces a share offering.
739247
Plus, Amgen's next blockbuster, and wish upon a Starbucks.
642785
As a looming battle with Roche approaches, Amgen is preparing to defend its anemia franchise, now worth $7 billion a year, through pricing and lawsuits.
294
Spotting the next disruptive technology, understanding the future and expecting less from insurance.
480772
Biotech company buys itself a bigger future.
10434
This stock could keep you and your portfolio both looking young and healthy.